Precocious puberty is a common pediatric endocrine disorder characterized by early onset of puberty. Current research suggests that the occurrence of this condition is related to multiple factors such as genetics, diet, and environment. Children with precocious puberty experience advanced bone age development, early closure of epiphyseal plates, and shortened growth periods. Since children’s intellectual and psychological development levels remain at their actual age, but their physical development is advanced, this can cause significant adverse effects on their physical growth and psychological health in the short term. In the long term, it may result in shorter adult height, reproductive health issues, and increased risks of breast cancer, metabolic diseases, and cardiovascular diseases. In terms of treatment, Western medicine primarily uses gonadotropin-releasing hormone analogues (GnRHa), while traditional Chinese medicine (TCM) focuses on syndrome differentiation and treatment. In recent years, discussions on treatment options for precocious puberty have gained traction. This paper comprehensively elaborates on the progress in treatment options for precocious puberty, aiming to provide reference and guidance for future clinical diagnosis and treatment.